NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
1.313
+0.013 (1.02%)
Nov 21, 2024, 10:56 AM EST - Market open
NextCure Market Cap
NextCure has a market cap or net worth of $36.74 million as of November 21, 2024. Its market cap has increased by 15.49% in one year.
Market Cap
36.74M
Enterprise Value
-32.82M
1-Year Change
15.49%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $36.74M, a decrease of -91.58%. That is a compound annual growth rate of -36.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 36.37M | 14.33% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | 300.33M | -80.57% |
| Dec 31, 2019 | 1.55B | 254.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Incannex Healthcare | 37.93M |
| Lexaria Bioscience | 37.87M |
| Beyond Air | 37.87M |
| Lumos Pharma | 37.45M |
| RAPT Therapeutics | 37.41M |
| Eterna Therapeutics | 36.22M |
| Carisma Therapeutics | 36.20M |
| Dyadic International | 36.10M |